Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acetyl- l -carnitine deficiency in patients with major depressive disorder
Carla Nasca, Benedetta Bigio, Francis S. Lee, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 34, pp. 8627-8632
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Maija Dambrova, Marina Makrecka-Kūka, Janis Kuka, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 506-551
Open Access | Times Cited: 278
Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
María S. García‐Gutiérrez, Francisco Navarrete, F. Sala, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 242
Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue
Laurence Dion‐Albert, Alice Cadoret, Ellen Doney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 162
Multi-omics signatures of the human early life exposome
Léa Maître, Mariona Bustamante, Carles Hernández-Ferrer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 120
Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance
Carla Nasca, Josh Dobbin, Benedetta Bigio, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 9, pp. 5140-5149
Open Access | Times Cited: 91
Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases
Marcela Konjevod, Matea Nikolac Perković, Jorge Sáiz, et al.
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 194, pp. 113681-113681
Closed Access | Times Cited: 79
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 73
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
Siamak MahmoudianDehkordi, Ahmed T. Ahmed, Sudeepa Bhattacharyya, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 71
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 71
Pathogenesis and treatment of depression: Role of diet in prevention and therapy
Weronika Mrozek, Justyna Socha, Klara Sidorowicz, et al.
Nutrition (2023) Vol. 115, pp. 112143-112143
Open Access | Times Cited: 40
Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
Shivanshu Bajaj, Radhakrishnan Mahesh
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 10
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort
Silvia Montanari, Rick Jansen, Daniela Schranner, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The impact of chronic stress on energy metabolism
Michael A. van der Kooij
Molecular and Cellular Neuroscience (2020) Vol. 107, pp. 103525-103525
Closed Access | Times Cited: 57
Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention
A.C. Rossetti, Maria Serena Paladini, Marco Andrea Riva, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107520-107520
Closed Access | Times Cited: 56
Metabolic signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-carnitine
Antoine Cherix, Thomas Larrieu, Jocelyn Grosse, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 55
How does the skeletal muscle communicate with the brain in health and disease?
Alinny Rosendo Isaac, Ricardo A. S. Lima-Filho, Mychael V. Lourenco
Neuropharmacology (2021) Vol. 197, pp. 108744-108744
Closed Access | Times Cited: 55
Acetyl-L-carnitine in chronic pain: A narrative review
Piercarlo Sarzi‐Puttini, Valeria Giorgi, Simona Di Lascio, et al.
Pharmacological Research (2021) Vol. 173, pp. 105874-105874
Closed Access | Times Cited: 42
Effects of pharmacological treatment on metabolomic alterations in animal models of depression
Juncai Pu, Yiyun Liu, Siwen Gui, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Connecting the biology of stress, allostatic load and epigenetics to social structures and processes
Craig A. McEwen
Neurobiology of Stress (2022) Vol. 17, pp. 100426-100426
Open Access | Times Cited: 29
Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients
Quentin Leyrolle, Renáta Cserjési, Maria D.G.H. Mulders, et al.
Clinical Nutrition (2020) Vol. 40, Iss. 4, pp. 2035-2044
Open Access | Times Cited: 48
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes
Ahmed T. Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Journal of Affective Disorders (2019) Vol. 264, pp. 90-97
Open Access | Times Cited: 46
Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence
Cara T. Hoepner, Roger S. McIntyre, George I. Papakostas
Nutrients (2021) Vol. 13, Iss. 3, pp. 767-767
Open Access | Times Cited: 40
Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
Hyuntae Park, Jongmin Kim, S. Ahn, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5398-5398
Open Access | Times Cited: 36
A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression
Helena U. Zacharias, Johannes Hertel, Hamimatunnisa Johar, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7372-7383
Open Access | Times Cited: 34
Carnitine and Depression
Ting Liu, Kunhong Deng, Ying Xue, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top